Keith W. Pfeil is a seasoned executive with over two decades of experience in finance and operations within the healthcare and medical device sectors. He holds a Bachelor of Science in Accounting from Pennsylvania State University and is a Certified Public Accountant (CPA). Pfeil began his career at Ernst & Young, where he honed his expertise in auditing and financial consulting for public companies. He later transitioned to leadership roles at companies like Stryker Corporation, where he served in various finance positions, contributing to strategic acquisitions and operational efficiencies that drove significant revenue growth. His deep understanding of regulatory compliance, financial planning, and supply chain management has made him a pivotal figure in scaling high-growth organizations. At Globus Medical Inc., a leading innovator in musculoskeletal solutions, Pfeil serves as both Chief Operating Officer (COO) and Chief Financial Officer (CFO), a dual role he assumed in 2020. In this capacity, he oversees the company's global financial strategy, including budgeting, investor relations, and risk management, while also directing operational functions such as manufacturing, supply chain, and quality assurance. Under his leadership, Globus Medical has achieved notable milestones, including expanding its product portfolio through strategic mergers and acquisitions, enhancing operational resilience during economic challenges, and delivering consistent double-digit revenue growth. Pfeil's focus on cost optimization and innovation has been instrumental in positioning the company as a market leader in spinal and orthopedic implants. Beyond his corporate achievements, Pfeil is recognized for his commitment to fostering a culture of financial discipline and operational excellence at Globus Medical. He has played a key role in navigating the company through the complexities of the COVID-19 pandemic, implementing agile strategies that minimized disruptions and accelerated recovery. Pfeil's forward-thinking approach continues to drive Globus Medical's expansion into new markets, ensuring sustainable value for shareholders and advancing patient care through cutting-edge medical technologies.